Showing 4 posts of 79 posts found.

Spiriva partners defend drug’s safety

October 2, 2008
Sales and Marketing Boehringer, COPD, Spiriva, resp

Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …

Almirall expands its horizons

July 3, 2008
Research and Development, Sales and Marketing Almirall, COPD, Spain

Almirall has been Spain's number one pharmaceutical company for some years, but is still little known outside its home market. …

Groundbreaking pharma-NHS collaboration launched in Nottingham

May 30, 2008
ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working

A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …

New antibody could be COPD breakthrough, say companies

November 21, 2005
Research and Development Argenta, COPD, Domantis

 Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …

Latest content